PRINCIPAL DISPLAY PANEL - 300 mL Bag Label
300 mL
NDC 0409-4883-11
Linezolid Injection
in 0.9% Sodium Chloride
600 mg/300 mL
(2 mg/mL)
For Intravenous Infusion
EACH ML CONTAINS LINEZOLID,
2 MG; CITRIC ACID ANHYDROUS, USP,
1.92 MG; SODIUM HYDROXIDE, 0.76 MG;
SODIUM CHLORIDE, USP 9 MG IN WATER
FOR INJECTION. ADJUST pH TO 4.4 -
5.2 WITH SODIUM HYDROXIDE AND/OR
HYDROCHLORIC ACID.
STERILE AND NON-PYROGENIC. SINGLE-
DOSE CONTAINER. DOSAGE AND USE:
SEE INSERT. STORE AT 20 TO 25°C
(68 TO 77°F). EXCURSIONS PERMITTED
TO 15 TO 30°C (59 TO 86°F). [SEE USP
CONTROLLED ROOM TEMPERATURE.]
PROTECT FROM FREEZING. LINEZOLID
IS SENSITIVE TO LIGHT. RETAIN
IN OVERWRAP PRIOR TO USE. USE
ONLY IF SOLUTION IS CLEAR AND
CONTAINER IS UNDAMAGED. MUST
NOT BE USED IN SERIES CONNECTIONS.
VisIV IS A TRADEMARK OF HOSPIRA. DO
NOT REMOVE CAPS UNTIL READY FOR
USE. IF LEAKS ARE FOUND, DISCARD
SOLUTION AS STERILITY MAY BE
IMPAIRED.
VisIV™ Container
Rx ONLY
5
PP
IM-5097
HOSPIRA, INC.,
LAKE FOREST, IL 60045 USA
Hospira
SET
